HL

Hasmukh Lalwani

Director Director DIN 00406033
DIN 00406033 First appointment Aug 2004 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2004
Shareholding value Locked Premium profile

About Hasmukh Lalwani

Data last updated:

Hasmukh Lalwani has 22 years in corporate governance. Formerly with 1 company, such as Pharmaids Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00406033
Primary Designation Director
First Appointment 21 Aug 2004
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Pharmaids Pharmaceuticals Limited L52520KA1989PLC173979
Director21 Aug 20041989Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pharmaids Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Hasmukh Lalwani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hasmukh Lalwani

Hasmukh Lalwani has 22 years in corporate governance. Formerly with 1 company, such as Pharmaids Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

Hasmukh Lalwani is associated with 0 companies as a director.

Hasmukh Lalwani has expertise in General Business.

Hasmukh Lalwani has 22 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available